Mirion Technologies, Inc. Acquires Dosimetry Services Distributor Based in Clinton, Tennessee
November 02 2021 - 4:05PM
Business Wire
Mirion Technologies, Inc. (“Mirion”), a global provider of
detection, measurement, analysis and monitoring solutions to the
medical, nuclear, defense, and research end markets, today
announced the acquisition of CHP Dosimetry, a U.S.-based
distributor of dosimetry services. The acquisition closed on
November 1, 2021.
Headquartered in Clinton, TN, CHP Dosimetry provides dosimetry
services for medical practices, veterinary offices, universities,
and government agencies, as well as industrial and environmental
companies. CHP Dosimetry was founded in 2004 and is a veteran-owned
small business (VOSB). The company recorded $1.2 million in revenue
for the year ended December 31, 2020.
CHP Dosimetry is a current customer of Mirion, with CHP
Dosimetry offering customers access to several Mirion-branded
solutions including its flagship innovation, the Instadose®*
dosimetry monitoring platform. Instadose dosimetry is a SMARTER
personal dosimeter technology that eliminates the need to collect
and return badges every wear period. Providing on-demand and
automatic dose reads and insights, Instadose dosimeters enable
instant access to current and historical exposure data and
cumulative dose insights, along with the ability to make account,
location, device, and wearer changes online within minutes.
“As the sole supplier of dosimetry offerings for CHP Dosimetry,
acquiring the company’s distribution channels marks a natural
progression for our business,” says Lou Biacchi, President of
Mirion Dosimetry Services. “We are excited to directly serve CHP
Dosimetry’s existing customers who we expect will continue to
utilize Mirion’s robust dosimetry products.”
Mirion provides personal radiation monitoring services and
dosimetry solutions for a wide range of applications. Personal
dosimeters are typically worn by individuals (clipped to their
collar, torso, waist, wrist or worn as a ring on their finger) who
work with or around sources of ionizing radiation and are used to
measure, record, and track the radiation dose they are exposed to
while performing their job.
*Instadose® dosimeters may not be accredited in all countries.
Please call 800-251-3331 for more information about international
availability.
Resources
- For more information on ionizing radiation, visit:
https://www.mirion.com/learning-center/radiation-safety-basics/types-of-ionizing-radiation
- The International Atomic Energy Agency (IAEA) Safety Standards,
Occupational Radiation Protection, General Safety Guide (GSG-7) can
be viewed here:
https://www-pub.iaea.org/MTCD/Publications/PDF/PUB1785_web.pdf
- To learn more about how Instadose wireless dosimetry is
revolutionizing personal radiation monitoring, view this video:
https://www.youtube.com/watch?v=Mqyku6oFh3k
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of Section 21E of the Securities Exchange Act of 1934.
Words such as “anticipate,” “believe,” “continue,” “could,”
“estimate”, “expect”, “hope”, “intend”, “may”, “might”, “should”,
“would”, “will”, “understand” and similar words are intended to
identify forward looking statements. These forward-looking
statements include but are not limited to, statements regarding the
benefits of CHP Dosimetry’s technology to Mirion and its customers,
and Mirion’s dosimetry operations. There are a significant number
of factors that could cause actual results to differ materially
from statements made in this press release, including the risk that
problems may arise in integrating CHP Dosimetry’s business and
technology.
Additional risks and uncertainties that could affect the
forward-looking statements in this press release are included under
the captions “Risk Factors” and “Management’s Discussion and
Analysis of Financial Condition and Results of Operations” set
forth from time to time in filings and reports we make from time to
time with the Securities and Exchange Commission, including our
registration statement on Form S-1 filed on October 27, 2021.
You should not rely on these forward-looking statements, as
actual outcomes and results may differ materially from those
contemplated by these forward-looking statements as a result of
such risks and uncertainties. All forward-looking statements in
this press release are based on information available to us as of
the date hereof, and we do not assume any obligation to update the
forward-looking statements provided to reflect events that occur or
circumstances that exist after the date on which they were
made.
About Mirion
Mirion Technologies is a leading provider of detection,
measurement, analysis and monitoring solutions to the nuclear,
defense, medical and research end markets. The organization aims to
harness its unrivaled knowledge of ionizing radiation for the
greater good of humanity. Headquartered in Atlanta (GA – USA),
Mirion employs around 2,500 people and operates in 13 countries.
For more information, and for the latest news and content from
Mirion, visit Mirion.com.
About CHP Dosimetry
Founded in 2004, CHP Dosimetry is a veteran-owned distributor of
dosimetry services based in Clinton, TN. CHP Dosimetry supplies
whole-body dosimeters, extremity rings, and area monitors to tens
of thousands of clients nationwide. Clients include medical
practices, veterinary offices, universities, government agencies,
and industrial and environmental companies. For more information,
visit chpdosimetry.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211102005926/en/
For investor inquiries: Brian Schopfer ir@mirion.com
For media inquiries: Matthew Maddox
mmaddox@mirion.com
Mirion Technologies (NYSE:MIR)
Historical Stock Chart
From May 2024 to Jun 2024
Mirion Technologies (NYSE:MIR)
Historical Stock Chart
From Jun 2023 to Jun 2024